Pilgrim's Pride Board Says It Won't Approve A JBS Buyout Without Its Independent Committee's Backing
Any deal is also expected to need a majority of votes cast by shareholders not held by JBS or its affiliates.
Pilgrim's Pride's board has formed a committee of independent directors to review JBS N.V.'s unsolicited proposal to buy every share of the chicken processor that JBS does not already own, the company said in an 8-K filed Friday. The board added that it will not approve a deal without the committee's favorable recommendation.
What the 8-K and press release say
The 8-K says the board formed a special committee of independent and disinterested directors. Its job is to evaluate JBS's offer, which the company received on August 18, 2026 and had announced earlier.
In the press release filed as Exhibit 99.1, the company said the board "will not approve the transaction proposed by JBS without the favorable recommendation of the special committee."
The company also said any such deal is expected to be conditioned on the affirmative vote of a majority of the votes cast by holders of shares not held by JBS or its affiliates.
The committee has picked Ropes & Gray as its legal counsel and Moelis & Company as its financial advisor.
What it changes for holders
If you own the stock, the structure matters more than the process. JBS is already a shareholder, so the board has put two gates in front of its proposal: a committee veto, and an expected vote in which JBS's own shares and those of its affiliates do not count.
The company was explicit that nothing is settled. It said there is no assurance a definitive agreement will be signed or that any transaction will be completed.
The release describes Pilgrim's Pride as employing about 63,000 people, with processing and prepared-foods plants in 14 states, Puerto Rico, Mexico, the U.K., the Republic of Ireland and continental Europe.
What to watch
The next signal is whether the committee recommends for or against the JBS proposal, and whether the two sides reach a definitive agreement. The filings give no dates for either.
Until the committee reports, the only formal position on record is the board's: no deal without its committee's recommendation, and an expected vote of shareholders unaffiliated with JBS.
